Copy Link Print Information

APTO-253 hydrochloride

(Synonyms: LOR-253 hydrochloride; LT-253 hydrochloride)
21 Cited Publications
Customer Review

Based on 21 publication(s) in Google Scholar

APTO-253?(LOR-253) hydrochloride is a small molecule that inhibits c-Myc expression, stabilizes G-quadruplex DNA and induces cell cycle arrest and apoptosis in acute myeloid leukemia cells. APTO-253?hydrochloride mediates anticancer activity via induction of Kruppel-like factor 4?(KLF4)?tumor suppressor. APTO-253?hydrochloride exhibits antiarthritic activity.

For research use only. We do not sell to patients.

  • CAS No.: 1691221-67-6
  • Formula: C22H14FN5
  • Molecular Weight:367.38
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • APTO-253 hydrochloride Chemical Structure
    APTO-253 hydrochloride Chemical Structure
  • Experimental Validation Results for APTO-253 hydrochloride
  • Experimental Validation Results for APTO-253 hydrochloride
  • Experimental Validation Results for APTO-253 hydrochloride
  • Experimental Validation Results for APTO-253 hydrochloride
  • Experimental Validation Results for APTO-253 hydrochloride
CAS No.: 1691221-67-6
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Other Forms of APTO-253 hydrochloride:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) APTO-253 hydrochloride

More
Customer Validation & Images
Cell Proliferation/Viability AssayRT-PCRWBIn Vivo Efficacy Study
  • Cell Proliferation/Viability Assay
  • WB
  • WB
  • RT-PCR
  • In Vivo Efficacy Study
Keywords
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Register
Sign in to MedChemExpress
Register New Account

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • APTO-253 hydrochloride Chemical Structure
    APTO-253 hydrochloride Chemical Structure
    1/16
  • 1/16

    APTO-253 hydrochloride purchased from MedChemExpress. Usage Cited in: Blood. 2024 Aug 16:blood.2023023644. [Abstract]

    Customer Validation
     Cell viability of OCI-AML2 cells expressing either sgLuc or sgPCGF1 was assessed under the treatment of APTO-253 (100 nM; 9 d).

  • 1/16

    APTO-253 hydrochloride purchased from MedChemExpress. Usage Cited in: Nat Commun. 2023 Sep 2;14(1):5360. [Abstract]

    Customer Validation
     APTO-253 (10 μM) reversed the effects of FAM3A on suppressing the expression of the markers for macrophages (CD68) and osteoblasts (OPN, RUNX2) in VSMCs.

  • 1/16

    APTO-253 hydrochloride purchased from MedChemExpress. Usage Cited in: Nat Commun. 2023 Sep 2;14(1):5360. [Abstract]

    Customer Validation
     KLF4 inducer APTO-253 (1 μg/g; i.p.; once daily for 4 weeks) significantly abrogated the effects of FAM3A on maintaining the contractile phenotype of VSMCs in aortas from AngII-ApoE−/− murine AAA models.

  • 1/16

    APTO-253 hydrochloride purchased from MedChemExpress. Usage Cited in: Ann Rheum Dis. 2021 Apr;80(4):440-450. [Abstract]

    Customer Validation
     APTO-253 (1-4 μM) reduced mRNA levels of 8-mix SE-contacted genes (IL-6, CCL5) in stimulated RASFs.

  • 1/16

    APTO-253 hydrochloride purchased from MedChemExpress. Usage Cited in: Ann Rheum Dis. 2021 Apr;80(4):440-450. [Abstract]

    Customer Validation
     APTO-253 (15 mg/kg; i.v.; twice per day for two consecutive days per week) demonstrated significant therapeutic activity in collagen-induced arthritis (CIA) mice.

  • APTO-253 hydrochloride